AXDX logo

Accelerate Diagnostics, Inc.


AXDX: Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.


Show AXDX Financials

Consumer Interest
SEC Filings

Recent trades of AXDX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AXDX's directors and management

Government lobbying spending instances

  • $10,000 Nov 06, 2017 Issue: Medical/Disease Research/Clinical Labs Science/Technology
  • $10,000 Jul 17, 2017 Issue: Science/Technology
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard

Number of mentions of AXDX in WallStreetBets Daily Discussion


Recent insights relating to AXDX

CNBC Recommendations

Recent picks made for AXDX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AXDX

Corporate Flights

Flights by private jets registered to AXDX